000			01524 a2200457 4500
005			20250511183601.0
264		0	_c19921203
008			199212s 0 0 eng d
022			_a0007-1323
024	7		_a10.1002/bjs.1800790932 _2doi
040			_aNLM _beng _cNLM
100	1		_aArnestad, J P
245	0	0	_aIsolated hyperthermic liver perfusion with cytostatic-containing perfusate activates the complement cascade. _h[electronic resource]
260			_bThe British journal of surgery _cSep 1992
300			_a948-51 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aChemotherapy, Cancer, Regional Perfusion
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aComplement Activation _ximmunology
650	0	4	_aComplement C3a _xanalysis
650	0	4	_aComplement C5a _xanalysis
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHyperthermia, Induced
650	0	4	_aLiver _ximmunology
650	0	4	_aLiver Neoplasms _ximmunology
650	0	4	_aMale
650	0	4	_aMelphalan _xanalysis
650	0	4	_aMiddle Aged
700	1		_aBengtsson, A
700	1		_aBengtson, J P
700	1		_aHenriksson, B A
700	1		_aStenqvist, O
700	1		_aNaredi, P
700	1		_aHafström, L
773	0		_tThe British journal of surgery _gvol. 79 _gno. 9 _gp. 948-51
856	4	0	_uhttps://doi.org/10.1002/bjs.1800790932 _zAvailable from publisher's website
999			_c1429258 _d1429258